Quipt Home Medical Corp. (QIPT)
Mar 16, 2026 - QIPT was delisted
3.650
0.00 (0.00%)
Inactive · Last trade price on Mar 13, 2026
Quipt Home Medical Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Net Income | -10.26 | -6.76 | -2.78 | 4.84 | -6.17 | -4.57 |
Depreciation & Amortization | 41.41 | 44.58 | 36.1 | 23.04 | 17.79 | 14.54 |
Stock-Based Compensation | 2.96 | 2.48 | 5.28 | 5.49 | 4.95 | 0.17 |
Other Adjustments | 1.67 | 2.73 | 0.39 | -5.13 | 4.62 | 8.51 |
Change in Receivables | 4.25 | -3.29 | -3.06 | -0.2 | -0.87 | -5.12 |
Changes in Inventories | -2.38 | -3.42 | -0.06 | -2.42 | -0.09 | -1.73 |
Changes in Accrued Expenses | -2.64 | 3.13 | 3.12 | 2.9 | 0.3 | 1.75 |
Changes in Unearned Revenue | -0.72 | -0.94 | 0.24 | 0.03 | 0.33 | 0.37 |
Changes in Other Operating Activities | -0.63 | -3.12 | -2.24 | 0.45 | -0.86 | 0.12 |
Operating Cash Flow | 34.65 | 35.38 | 36.98 | 26.34 | 17.76 | 14.03 |
Operating Cash Flow Growth | -10.29% | -4.32% | 40.37% | 48.33% | 26.56% | 67.35% |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Capital Expenditures | -10.53 | -10.31 | -6.85 | -9.16 | -5.05 | -0.09 |
Sale of Property, Plant & Equipment | 1.02 | 0.21 | 0.07 | 0.19 | 0.1 | 0.25 |
Cash Acquisitions | - | -0.21 | -76.04 | -33.53 | -12.89 | -8.02 |
Investing Cash Flow | -12.97 | -10.31 | -82.83 | -42.49 | -17.84 | -7.85 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Short-Term Debt Issued | 12 | 17.1 | 16.5 | - | - | - |
Short-Term Debt Repaid | -17.79 | -10.78 | -23.5 | - | - | - |
Net Short-Term Debt Issued (Repaid) | -5.79 | 6.32 | -7 | - | - | - |
Long-Term Debt Issued | - | - | 64 | - | - | - |
Long-Term Debt Repaid | -29.98 | -31.82 | -23.92 | -15.72 | -12.96 | -12.97 |
Net Long-Term Debt Issued (Repaid) | -29.98 | -31.82 | 40.08 | -15.72 | -12.96 | -12.97 |
Issuance of Common Stock | - | 0.57 | 28.35 | 0.57 | 19.08 | 21.25 |
Repurchase of Common Stock | - | -0.21 | -1.34 | -1.1 | - | - |
Net Common Stock Issued (Repurchased) | - | 0.36 | 27.01 | -0.53 | 19.08 | 21.25 |
Other Financing Activities | -0.16 | -1 | -5.66 | 6.4 | -1.27 | 5.44 |
Financing Cash Flow | -24.79 | -26.15 | 54.43 | -9.85 | 4.84 | 13.72 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Foreign Exchange Rate Adjustments | -0.04 | 0.04 | 0.11 | -0.1 | 0.62 | -0.38 |
Net Cash Flow | -3.2 | -1.08 | 8.59 | -26 | 4.76 | 19.9 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Free Cash Flow | 24.12 | 25.07 | 30.13 | 17.18 | 12.72 | 13.94 |
Free Cash Flow Growth | -19.28% | -16.79% | 75.34% | 35.14% | -8.81% | 98.48% |
FCF Margin | 10.50% | 10.19% | 14.23% | 12.29% | 12.42% | 19.19% |
Free Cash Flow Per Share | 0.56 | 0.59 | 0.78 | 0.47 | 0.42 | 0.61 |
Levered Free Cash Flow | -21.51 | -2.35 | 60.6 | 3.96 | -6.72 | -2.59 |
Unlevered Free Cash Flow | 20.42 | 31.04 | 33.25 | 22.64 | 11.46 | 15.63 |